| Study patients (n = 259) |
Age, yrs, mean ± SD | 76.6 ± 8.5 |
Sex ratio (male/female) | 125:134 |
Disease duration, yrs | 6.2 ± 5.1 |
Observation period, wks, median (range) | 54 (0 - 105) |
Underlying disease |
|
PD (n) | 220 (84.9%) |
H-Y stage, mean ± SD | 3.1 ± 1.0 |
PSP, n (%) | 29 (11.2%) |
MSA, n (%) | 7 (2.7%) |
CBS, n (%) | 3 (1.2%) |
Subjects who interrupted, n (%) PD, n (%) PSP, n (%) MSA, n (%) CBS, n (%) Period until interruption, wks (range) Subjects who restarted PD, n (%) PSP, n (%) MSA, n (%) CBS, n (%) Period until restart, wks, median (range)s | 133 (51.4%) 109/220 (49.5%) 17/29 (58.6%) 5/7 (71.4%) 2/3 (66.7%) 39 (0 - 104) 29 (21.8%) 26/109 (23.9%) 1/17 (5.9%) 0/5 (0%) 2/2 (100%) 10 (2 - 40) |